Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tianna Magel, Elizabeth Matzinger, Sarah Blawatt, Scott Harrison, Scott MacDonald, Sherif Amara, Rebecca Metcalfe, Nick Bansback, David Byres, Martin Schechter & Eugenia Oviedo-Joekes. (2024) How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives. Drugs: Education, Prevention and Policy 31:2, pages 200-211.
Read now
Read now
Articles from other publishers (3)
Samara Mayer, Emily Jenkins, Nadia Fairbairn, Al Fowler & Ryan McNeil. (2024) “I'm just searching to get better”: Constructions of treatment citizenship on injectable opioid agonist treatment. Social Science & Medicine 348, pages 116708.
Crossref
Crossref
Eugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, Scott MacDonald, Cheryl McDermid, Piotr Klakowicz, Scott Harrison, Julie LaJeunesse, Nancy Chow, Murray Brown, Sam Gill & Martin Schechter. (2023) Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study. BMC Health Services Research 23:1.
Crossref
Crossref
Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, Heather Palis, Kirsten Marchand, Scott Harrison, Scott MacDonald, David Byres, Martin Schechter, Nick Bansback & Eugenia Oviedo-Joekes. (2023) Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling). International Journal of Drug Policy 112, pages 103948.
Crossref
Crossref